Boston Scientific Corporation

BSX | NYSE

$43.22

+$1.24 (+2.95%)

Nov 2, 2026, 10:35 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	2.89B	1.85B	1.59B	698M	1.04B	-82M
Depreciation & Amortization	1.37B	1.27B	1.2B	1.14B	1.09B	1.12B
Stock-Based Compensation	299M	266M	233M	220M	194M	170M
Other Working Capital	-85M	-126M	10M	-209M	-134M	-316M
Other Non-Cash Items	223M	586M	253M	540M	18M	337M
Deferred Income Tax	-2M	-70M	-1M	-63M	-124M	-82M
Change in Working Capital	-246M	-462M	-770M	-1.01B	-351M	42M
Operating Cash Flow	4.53B	3.44B	2.5B	1.53B	1.87B	1.51B
Capital Expenditures	-876M	-790M	-800M	-612M	-554M	-376M
Cash Acquisitions	-1.59B	-4.64B	-1.81B	-1.54B	-1.43B	12M
Purchase of Investments	n/a	n/a	n/a	-24M	96M	-146M
Sales Maturities Of Investments	n/a	n/a	n/a	56M	294M	12M
Other Investing Acitivies	-171M	-257M	-52M	106M	-1M	87M
Investing Cash Flow	-2.64B	-5.69B	-2.57B	-2.01B	-1.6B	-411M
Debt Repayment	-491M	1.83B	-4M	-165M	n/a	-999M
Common Stock Repurchased	n/a	n/a	n/a	136M	n/a	-535M
Dividend Paid	n/a	n/a	-28M	-55M	-55M	-28M
Other Financial Acitivies	-186M	-243M	-145M	-464M	-150M	-95M
Financial Cash Flow	-395M	1.81B	5M	-548M	-95M	293M
Net Cash Flow	1.54B	-449M	-82M	-1.04B	171M	1.39B
Free Cash Flow	3.66B	2.65B	1.7B	914M	1.32B	1.13B
Adj. Free Cash Flow	3.36B	2.38B	1.47B	694M	1.12B	962M
Maintenance CapEx	-115.21M	-227.65M	-456.91M	-441.31M	-135.93M	-376M
Growth CapEx	-760.79M	-562.35M	-343.09M	-170.69M	-418.07M	n/a
Owner Earnings	4.42B	3.21B	2.05B	1.08B	1.73B	1.13B